Cargando…
Bioavailability of Orally Administered rhGM-CSF: A Single-Dose, Randomized, Open-Label, Two-Period Crossover Trial
BACKGROUND: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) is usually administered by injection, and its oral administration in a clinical setting has been not yet reported. Here we demonstrate the bioavailability of orally administered rhGM-CSF in healthy volunteers....
Autores principales: | Zhang, Wenping, Lv, Zhengbing, Nie, Zuoming, Chen, Guogang, Chen, Jian, Sheng, Qing, Yu, Wei, Jin, Yongfeng, Wu, Xiangfu, Zhang, Yaozhou |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677157/ https://www.ncbi.nlm.nih.gov/pubmed/19434235 http://dx.doi.org/10.1371/journal.pone.0005353 |
Ejemplares similares
-
Topically administered rhGM-CSF affects PPARβ expression in the stasis zone
por: Fu, Gen-Feng, et al.
Publicado: (2017) -
rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.
por: Rampling, R., et al.
Publicado: (1994) -
Tumor growth under rhGM-CSF application in an orthotopic rodent glioma model
por: Linsenmann, Thomas, et al.
Publicado: (2019) -
Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)
por: Gajewska, Marta E., et al.
Publicado: (2018) -
Characterization of a novel + 70 Da modification in rhGM-CSF expressed in E. coli using chemical assays in combination with mass spectrometry
por: Sandberg, Magdalena Widgren, et al.
Publicado: (2021)